Fisher & Paykel Healthcare dodges worst of US tariff risk: Jarden

Fisher & Paykel Healthcare dodges worst of US tariff risk: Jarden
About 43% of Fisher & Paykel Healthcare’s revenue comes from the US. (Image: Supplied)
John Anthony
Jarden has raised its rating and target share price for Fisher & Paykel Healthcare by 10%, as Thursday’s US tariff announcements proved less damaging than expected.Following US President Donald Trump’s unveiling of “Liberation Day” tariffs, shares in Fisher & Paykel Healthcare (FPH), a company with significant export exposure to the US, traded as low as $32.60 in the wake of the announcement on Thursday. They were currently at $34.80.In a research note released late Thursday evening, Jarden analysts Adrian Allbon...

More Economy

Government keeps AA+ credit rating, Fitch warns to keep ‘culture of fiscal responsibility
Economy

Government keeps AA+ credit rating, Fitch warns to keep ‘culture of fiscal responsibility

The Government has kept its AA+ credit rating from Fitch, one of the big three ratings agencies – but the agency warned that a slackening culture of fiscal responsibility, a more severe housing market correction, or an unemployment spike could see the rating reduced in future.The...

Staff reporters 18 Aug 2025
Gas insider explains energy pain and solutions
Economy

Gas insider explains energy pain and solutions

Find more energy or face ongoing deindustrialisation, says GIC.

Ian Llewellyn 18 Aug 2025
RBNZ seen cutting OCR by 25 bps, flagging easing bias
Economy

RBNZ seen cutting OCR by 25 bps, flagging easing bias

RBNZ is expected to cut its OCR rate to 3% on Wednesday.

Staff reporters 18 Aug 2025